RGV Endocrine Center has several ongoing clinical trials which are recruiting for patients with Type 1 and Type 2 Diabetes.
- Eversense Implantable Continuous Glucose Monitor (CGM) Study (NA-PAS)
- GLP-1* Use in Diabetic Patients (ACHIEVE-4)
- Kidney Disease in Diabetic Patients (CONFIDENCE)
- Kerendia (Finerenone) Long Term Outcomes Study (FINE-REAL)
- Cardiovascular study to reduce risk of Heart Attack and Stroke in Diabetic Patients (ZEUS)
If you are interested in participating please Contact Us or call our research department at (956)278-0366.
*GLP-1's are a drug class of once weekly injections indicated for treating diabetes and obesity such as Ozempic, Mounjaro and Wegovy.